Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors
Margaret Ann Kreher, Sailesh Konda, Mary Margaret B. Noland, María Isabel Longo, Rodrigo Valdés‐Rodríguez
Topics & Concepts
MedicineSkin cancerTofacitinibImmunosuppressionEfalizumabAbataceptImmunologyOncologyCancerInternal medicineInfliximabRheumatoid arthritisTumor necrosis factor alphaRituximabLymphomaNonmelanoma Skin Cancer StudiesPolyomavirus and related diseasesCutaneous lymphoproliferative disorders research